Quick answer
This page lists 29 targeted therapy doctors in Delhi NCR, India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.
About Targeted Therapy doctors in Delhi NCR, India
This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.
Targeted Therapy doctors
FeaturedDr. Vinod Raina
MBBS, MD (Internal Medicine), DM (Medical Oncology), Fellowship, Fellowship
Chairman – Medical Oncology · Specialty: Medical Oncologist
Fortis Memorial Research Institute Gurgaon, India40+ Years experience
Why consider this doctor?
- 40+ years of experience in Medical Oncologist
- Chairman – Medical Oncology, Fortis Memorial Research Institute, Gurugram (Present)
- Professor and Head of Medical Oncology, AIIMS, New Delhi (2001 – 2013)
Expertise & Procedures
- High-Dose Chemotherapy with Stem Cell Rescue
- Autologous Bone Marrow Transplant
- Chemotherapy (Induction, Consolidation, Maintenance)
- Concurrent Chemoradiotherapy
- Palliative Chemotherapy
Medical Oncologist Experience: 40+ YearsHospital Affiliation: Fortis Memorial Research InstituteHospital accreditation: JCI, NABH
Dr. Pooja Babbar
MBBS, MD Radiation Oncology, Senior Residency, DM Medical Oncology – Gold Medalist, European Certification in Medical Oncology (ESMO), Diploma in Medico Legal System, MBA in Hospital Management
Consultant & Unit Head – Medical Oncology · Specialty: Medical Oncologist
Fortis Hospital Manesar Gurugram, India11+ Years experience
Why consider this doctor?
- 11+ years of experience in Medical Oncologist
- Consultant & Unit Head – Medical Oncology, Fortis Hospital, Manesar, Gurugram (Present)
- American Oncology Institute, Gurugram
Expertise & Procedures
- Chemotherapy (Adjuvant, Neoadjuvant, Palliative)
- Immunotherapy (Checkpoint Inhibitors)
- Targeted Therapy (HER2, EGFR, VEGF, CDK4/6 inhibitors)
- Hormonal Therapy (Breast, Prostate cancer)
- Oncological Emergency Management
Medical Oncologist Experience: 11+ YearsHospital Affiliation: Fortis Hospital ManesarHospital accreditation: NABH, NABL, JCI
Dr. Imran Khan
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP — Medical Oncology
Consultant — Medical Oncology · Specialty: Medical Oncologist
Fortis Escorts Heart Institute New Delhi, India10+ Years experience
Why consider this doctor?
- 10+ years of experience in Medical Oncologist
- Consultant — Medical Oncology, Fortis Escorts, Okhla Road, New Delhi (Present)
- Associate Consultant — Medical Oncology, Fortis Escorts, Amritsar
Expertise & Procedures
- Chemotherapy Administration
- Targeted Therapy Infusions
- Immunotherapy Infusions
- PICC Line Insertion
- Bone Marrow Aspiration & Biopsy
Medical Oncologist Experience: 10+ YearsHospital Affiliation: Fortis Escorts Heart InstituteHospital accreditation: JCI, NABH
Dr. Dipanjan Panda
MBBS, MD (General Medicine), DM (Medical Oncology)
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Indraprastha Apollo Hospitals New Delhi, India15+ Years experience
Why consider this doctor?
- 15+ years of experience in Medical Oncologist
- Senior Consultant — Medical Oncology, Indraprastha Apollo Hospitals, New Delhi (Present)
- Associate Professor & HOD — Medical Oncology, Institute of Liver and Biliary Sciences (ILBS), New Delhi
Expertise & Procedures
- Systemic chemotherapy for solid tumours
- Targeted therapy regimens
- Immunotherapy (checkpoint inhibitors)
- Oral chemotherapy management
- Adjuvant and neo-adjuvant cancer treatment planning
Medical Oncologist Experience: 15+ YearsHospital Affiliation: Indraprastha Apollo Hospitals
Dr. Ajay Sharma
MBBS, MD, DNB, ECMO
Senior Director & Unit Head — Medical Oncology · Specialty: Medical Oncologist
BLK-Max Super Speciality Hospital New Delhi, India18+ Years experience
Why consider this doctor?
- 18+ years of experience in Medical Oncologist
- Senior Director and Unit Head, Medical Oncology — BLK-Max Super Speciality Hospital, New Delhi (Present)
- Unit Head and Senior Consultant, Medical Oncology — Rajiv Gandhi Cancer Institute and Research Centre, New Delhi (2022–2023)
Expertise & Procedures
- Adjuvant chemotherapy for solid tumours
- Neoadjuvant chemotherapy planning and delivery
- Immunotherapy and checkpoint inhibitor therapy
- Hormone therapy for breast cancer
- Molecular-targeted therapy based on biomarkers
Medical Oncologist Experience: 18+ YearsHospital Affiliation: BLK-Max Super Speciality HospitalHospital accreditation: JCI, NABH
Dr. Anshul Gupta
MBBS, MD, DM (Medical Oncology)
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Indraprastha Apollo Hospital Delhi NCR, India12+ Years experience
Why consider this doctor?
- 12+ years of experience in Medical Oncologist
- Senior Consultant – Medical Oncology, Indraprastha Apollo Hospital, Delhi NCR, Present
- Medical Oncologist, AIIMS New Delhi, Previous roles
Expertise & Procedures
- Chemotherapy Administration & Management
- Immunotherapy (Checkpoint Inhibitors)
- Targeted Therapy for Cancer
- CAR-T Cell Therapy
- Hormone Therapy (Breast & Prostate)
Medical Oncologist Experience: 12+ YearsHospital Affiliation: Indraprastha Apollo HospitalHospital accreditation: JCI, NABH
Dr. Bhawna Dahiya
MBBS, MD, DM, ESMO Certification
Consultant — Medical Oncology · Specialty: Medical Oncologist
Sarvodaya Hospital Faridabad, India8+ Years experience
Why consider this doctor?
- 8+ years of experience in Medical Oncologist
- Consultant — Medical Oncology, Sarvodaya Hospital, Faridabad, Present
- Clinical Oncology Fellowship, Government Kilpauk Medical College, Chennai
Expertise & Procedures
- Chemotherapy Administration
- Immunotherapy for Cancer
- Targeted Therapy Planning and Monitoring
- CAR-T Cell Therapy
- Hormone Replacement Therapy for Cancer
Medical Oncologist Experience: 8+ YearsHospital Affiliation: Sarvodaya HospitalHospital accreditation: NABH, NABL
Dr. Bhuvan Chugh
MBBS, DNB (Medicine), DNB (Medical Oncology)
Lead Consultant — Medical Oncology · Specialty: Medical Oncologist
Indraprastha Apollo Hospital New Delhi, India15+ Years experience
Why consider this doctor?
- 15+ years of experience in Medical Oncologist
- Lead Consultant, Medical Oncology – Indraprastha Apollo Hospital, New Delhi
- Principal Consultant, Medical Oncology – Max Super Specialty Hospital, Saket, New Delhi
Expertise & Procedures
- Chemotherapy Administration and Management
- Cancer Immunotherapy Planning and Delivery
- Targeted Therapy for Breast and Lung Cancer
- Hormone Therapy for Breast Cancer
- CAR-T Cell Therapy Evaluation and Management
Medical Oncologist Experience: 15+ YearsHospital Affiliation: Indraprastha Apollo HospitalHospital accreditation: JCI, NABH
Dr. Anil Dhar
MBBS, MD, Post-doctoral training in Medical Oncology
Clinical Director & Head — Medical Oncology · Specialty: Medical Oncologist
Marengo Asia Hospitals Gurugram, India35+ Years experience
Why consider this doctor?
- 35+ years of experience in Medical Oncologist
- Clinical Director & Head, Medical Oncology – Marengo Asia Hospitals, Gurugram (Present)
- Senior Consultant & Mentor – Multiple Oncology Programs across India
Expertise & Procedures
- Adjuvant Chemotherapy for Solid Tumors
- Neoadjuvant Chemotherapy and Surgery Coordination
- Targeted Therapy with Biomarker Analysis
- Immunotherapy for Advanced Cancers
- Hormone Therapy for Breast Cancer
Medical Oncologist Experience: 35+ YearsHospital Affiliation: Marengo Asia HospitalsHospital accreditation: NABH, NABL
Dr. Chandragouda Dodagoudar
MBBS, MD (Medicine), DNB (Medical Oncology), ECMO
Senior Director & Unit Head — Medical Oncology · Specialty: Medical Oncologist
BLK-Max Super Speciality Hospital New Delhi, India22+ Years experience
Why consider this doctor?
- 22+ years of experience in Medical Oncologist
- Senior Director & Unit Head, Medical Oncology, BLK-Max Super Speciality Hospital, New Delhi — Present
- Consultant, Rajiv Gandhi Cancer Hospital, New Delhi
Expertise & Procedures
- Adjuvant Chemotherapy for Solid Tumors
- Neoadjuvant Chemotherapy and Preoperative Treatment
- Immune Checkpoint Inhibitor Therapy (PD-1, PD-L1, CTLA-4)
- Palliative Chemotherapy and Symptom Management
- Hormonal Therapy for Breast and Gynaecologic Cancers
Medical Oncologist Experience: 22+ YearsHospital Affiliation: BLK-Max Super Speciality HospitalHospital accreditation: JCI, NABH
Hospitals where these doctors practise
🇮🇳 Manesar, Gurgaon, IndiaStarting from$300
Fortis Hospital Manesar
Est. 2013
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditationJCI — Joint Commission International accreditation
Targeted TherapyMedical OncologyCardiac SurgeryOrthopedics
1+
Doctors for Targeted Therapy
4.4
74 reviews
350+
Beds
13+
Years Since Founded
🇮🇳 New Delhi, IndiaStarting from$300
Fortis Escorts Heart Institute
Est. 1988
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
Targeted TherapyMedical OncologyCardiac SurgeryCardiology
1+
Doctors for Targeted Therapy
4.5
24 reviews
310+
Beds
38+
Years Since Founded
🇮🇳 New Delhi, IndiaStarting from$300
BLK-Max Super Speciality Hospital
Est. 1959
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
Targeted TherapyMedical OncologyCardiac SurgeryCardiology
2+
Doctors for Targeted Therapy
3.8
48 reviews
650+
Beds
67+
Years Since Founded
🇮🇳 New Delhi, IndiaStarting from$300
Apollo Hospitals
Est. 1983
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
Targeted TherapyMedical OncologyCardiac SurgeryCardiology
2+
Doctors for Targeted Therapy
4.9
1240 reviews
1000+
Beds
43+
Years Since Founded
🇮🇳 Faridabad, IndiaStarting from$300
Sarvodaya Hospital
Est. 2014
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
Targeted TherapyMedical OncologyCardiac SurgeryCardiology
2+
Doctors for Targeted Therapy
4.5
74 reviews
450+
Beds
12+
Years Since Founded
🇮🇳 Chennai, IndiaStarting from$300
Apollo Hospitals, Greams Road
Est. 1983
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
Targeted TherapyMedical OncologyCardiac SurgeryCardiology
2+
Doctors for Targeted Therapy
4.7
125 reviews
560+
Beds
43+
Years Since Founded
🇮🇳 Sector 56, Gurgaon, IndiaStarting from$300
Marengo Asia Hospitals Gurgaon
Est. 1995
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
Targeted TherapyMedical OncologyCardiac SurgeryCardiology
1+
Doctors for Targeted Therapy
4.4
103 reviews
110+
Beds
31+
Years Since Founded
🇮🇳 Gurgaon, IndiaStarting from$300
Paras Hospitals
Est. 2006
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
Targeted TherapyMedical OncologyCardiac SurgeryCardiology
2+
Doctors for Targeted Therapy
4.4
59 reviews
300+
Beds
20+
Years Since Founded
Why consider treatment in India?
Many international patients consider India for lung cancer treatment for several reasons, including:
More affordable estimates
Competitive indicative costs compared with many other countries, for similar clinical standards.
Internationally accredited hospitals
Hospitals experienced in treating international patients.
Experienced specialists
Doctors who regularly manage similar cases.
Care coordination support
A team to help with planning, medical translation and follow-up.
About the Procedure
What is Targeted Therapy?
Targeted therapy uses drugs designed to specifically identify and attack cancer cells based on genetic mutations, proteins, or receptors, while sparing normal healthy cells. It is used across breast, lung, colorectal, gastric, liver, pancreatic, prostate, ovarian, head & neck cancers, leukemia, lymphoma, and multiple myeloma, often guided by biomarker or genomic testing. India offers internationally accredited cancer centres with access to the latest targeted agents at a fraction of Western costs.
Who may be considered?
Targeted Therapy may be considered after a qualified specialist reviews your reports and medical history. Suitability varies from person to person and must be assessed by your treating doctor.
How does it work?
Tumor tissue or blood samples are analyzed for specific mutations (e.g., HER2, EGFR, ALK, KRAS, BRCA) to determine eligibility for a matched targeted drug.
3 approaches available for this procedure:
Biomarker/Genomic Testing & Drug Selection
Essential First StepTumor tissue or blood samples are analyzed for specific mutations (e.g., HER2, EGFR, ALK, KRAS, BRCA) to determine eligibility for a matched targeted drug.
Comprehensive Investigations
Estimated cost: $300 - $1,500
Tumor biopsy, IHC/FISH testing, next-generation sequencing (NGS) panel, liquid biopsy, complete blood count (CBC), liver and kidney function tests
Treatment / Procedure Estimate
Estimated cost in India: $300 - $2,000
Stay in India
Pre-procedure stay (outside hospital): ~2 days
Hospitalisation: 0 days (outpatient)
Recovery period (outside hospital): ~1 day
Total stay: approx 3 days
Usually Included in Hospital Package
- Oncologist consultation
- Tissue/blood sample processing
- Genomic report interpretation
- Tumor board review
Usually Not Included
- International shipping of external samples
- Repeat biopsy if sample inadequate
- Second confirmatory pathology opinion
Recovery and follow-up
Most patients tolerate targeted therapy on an outpatient or short-stay basis, with periodic monitoring for side effects such as fatigue, skin reactions, or organ toxicity; response is typically reassessed via imaging every 2-3 treatment cycles.
Risks
Potential risks include infusion reactions, cardiotoxicity, skin and gastrointestinal side effects, elevated liver enzymes, and, less commonly, resistance development requiring drug switch.
Alternatives
Depending on cancer type and stage, alternatives may include conventional chemotherapy, immunotherapy, hormonal therapy, radiation, or surgical resection, often used in combination with or instead of targeted therapy.
What we need to prepare a formal estimate
Share whatever you have — the care team will confirm the final checklist after reviewing your case.
Reports required
- Histopathology and biopsy report
- IHC/FISH biomarker results (HER2, ER/PR, etc.)
- Next-generation sequencing (NGS) or mutation panel report
- Recent CT/PET-CT/MRI imaging
- Complete blood count and organ function tests
- Prior treatment and chemotherapy history
- Discharge summaries from previous hospitalizations
- Current medication list
Patient information needed
- Cancer type, stage, and site of primary tumor
- Prior treatments including surgery, chemotherapy, radiation
- Known genetic mutations or biomarker status if tested
- Current performance status and comorbidities
- Allergy history, especially to biologic drugs
- Cardiac history if cardiotoxic drugs are anticipated
- Insurance or budget considerations
- Availability of a caregiver/companion during treatment
Costs shown are indicative planning estimates based on typical pricing across leading Indian hospitals. They are not a quote — actual pricing depends on your case complexity, hospital choice, and length of stay. Share your reports for a personalized estimate.
How this directory is built
Doctors are matched using the specialty, location, condition (Targeted Therapy) and procedure (Targeted Therapy) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.
Need help with the next step?
Share your needs with our care coordination team for information about doctors and hospitals.
Common questions
FAQs about Targeted Therapy in Delhi NCR, India
What is Lung Cancer?
Lung cancer is a malignant condition in which cells in one or both lungs multiply abnormally, most commonly arising in the cells lining the airways (non-small cell lung cancer) or in neuroendocrine cells of the lung (small cell lung cancer). The distinction between these types, along with the tumour's stage and molecular profile, directly shapes the treatment approach.
What are the symptoms and health risks of Lung Cancer?
Common symptoms include a persistent or worsening cough, coughing up blood, unexplained shortness of breath, chest pain, hoarseness, unintentional weight loss, and recurrent chest infections. As the disease progresses or spreads, symptoms such as bone pain, headache, or swelling in the face and neck may also appear. It is important to note that these symptoms overlap with many other conditions, and their presence alone is not sufficient to establish a diagnosis.
How is Lung Cancer diagnosed?
Diagnosis typically begins with a detailed clinical history and physical examination, followed by chest X-ray or CT scan to identify suspicious lesions. A tissue biopsy — obtained bronchoscopically, via CT-guided needle, or surgically — is required to confirm the cancer type and, increasingly, to test for specific genetic mutations (such as EGFR, ALK, or PD-L1 expression) that guide targeted therapy decisions. Staging, usually described using the TNM system (Stage I through IV for non-small cell, and limited versus extensive for small cell), along with PET scan and sometimes brain MRI, determines how far the cancer has spread and which treatment pathways are appropriate.
How is Lung Cancer treated?
Treatment depends heavily on the cancer type, stage, molecular markers, and the patient's overall lung function and health status. Early-stage non-small cell lung cancer may be treated with surgery, stereotactic body radiation therapy (SBRT), or a combination of chemotherapy and radiation; advanced stages may involve systemic therapies such as chemotherapy, targeted agents, or immunotherapy, often combined with radiation therapy such as intensity-modulated radiation therapy (IMRT). Small cell lung cancer is generally managed with chemotherapy and radiation, and all decisions about sequencing and combining treatments are made by a multidisciplinary team following individual assessment.
Can Lung Cancer be treated without a procedure?
Non-surgical pathways are well established and clinically significant for lung cancer. Stereotactic body radiation therapy (SBRT) is a recognised standard for early-stage tumours in patients who are not surgical candidates or who prefer to avoid surgery. For locally advanced or metastatic disease, chemotherapy, immunotherapy, targeted molecular therapies, and radiation therapy (including IMRT) form the backbone of treatment — meaning many patients receive effective care without any surgical procedure.
When is Targeted Therapy considered for Lung Cancer?
Targeted Therapy may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.
Which doctor treats Lung Cancer?
Lung cancer is typically evaluated and managed by a multidisciplinary team that may include a thoracic oncologist or medical oncologist (who oversees systemic therapies), a radiation oncologist (who plans and delivers SBRT or IMRT), a thoracic surgeon (for surgical cases), and a pulmonologist involved in initial diagnosis. A dedicated lung cancer tumour board — where specialists review each case collectively — is considered best practice at experienced centres.
How do I choose a doctor for Lung Cancer?
When comparing providers, look for centres with a dedicated thoracic or lung cancer programme, access to molecular tumour profiling, and an active multidisciplinary tumour board, as these factors are associated with more personalised and coordinated care. It is also worth asking about the radiation oncology team's specific experience with SBRT and IMRT for lung tumours, the technology available (such as image-guided or motion-management systems), and what structured follow-up and supportive care are offered after treatment.
What documents do international patients need to share for a medical evaluation?
Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.
How does GAF Healthcare help international patients plan treatment in India?
Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.